Medical Director - Pathologist
Laboratory Corp of America
- Location
- Baltimore MD
- Work model
- On-Site
- Level
- Staff
- Posted
- Sep 10, 2026
About this role
Labcorp is a global leader in laboratory services, providing the insights and answers that help healthcare providers, patients, researchers, pharmaceutical companies and health systems make confident decisions and improve outcomes. Through our unparalleled science, data, technology and laboratory network, we advance diagnostics, accelerate innovation and help address some of the world’s most important health challenges. As we shape the future of healthcare, we are leveraging advanced technologies, intelligent digital solutions and data-driven innovation across our operations to enhance how work gets done and deliver greater value to customers and patients. With our global scale and deep expertise, you’ll have the opportunity to do meaningful work, grow your career and make a real impact on people’s health around the world. Together, we’re improving health and improving lives. PGDx by Labcorp is seeking a Medical Director - Pathologist to join our team in Baltimore, MD. Work Schedule: Monday - Friday, 1st shift Job Summary: The Medical Director - Pathologist provides on-site medical leadership for the Baltimore laboratory and supports Labcorp Oncology precision oncology testing. The role includes clinical interpretation and sign-out of tissue- and blood-based oncology testing; tissue adequacy review and quality control for PGDx assays, Plasma Detect Genome, and future oncology assays; and medical oversight of assay development, validation, clinical studies, companion diagnostic programs, and product launches. The position supports clinical quality, turnaround time, operational scale, and growth, with a primary focus on minimal residual disease (MRD).
Job Responsibilities
Review, interpret, and sign out tissue- and blood-based precision oncology cases in a timely manner. Provide on-site medical coverage and medical oversight for the Baltimore laboratory and the PGDx testing portfolio, including Plasma Complete, Plasma Detect, elio tissue complete (ETC), and elio plasma focus (EPF). Perform tissue adequacy review and quality control for PGDx assays, OmniSeq INSIGHT, Plasma Detect Genome, and future oncology assays, including landmark tissue assessment for tumor-informed MRD testing. Provide pathology leadership for Plasma Detect Genome V2 development and launch, including tissue quality-control processes, clinical validation, evidence-generation studies, and operational readiness. Provide pathology consultation for challenging specimens, test selection, case triage, and medical or technical questions. Support assay development, verification, validation, product enhancement, and launch activities for precision oncology products. Provide pathology leadership for clinical studies, evidence-generation programs, companion diagnostic activities, and biopharma collaborations. Contribute to study design, data interpretation, abstracts, presentations, peer-reviewed publications, and scientific meetings. Support quality systems, SOP development and review, quality metrics, proficiency and competency activities, investigations, corrective and preventive actions, accreditation requirements, laboratory inspections, and regulatory compliance. Collaborate with Medical Affairs, R&D, bioinformatics, digital pathology, data science, Operations, Quality, Commercial, marketing, customer service, and clinical teams. Provide medical and scientific support for provider inquiries, field education, product positioning, medical messaging, launch readiness, customer engagement, molecular tumor boards, webinars, and clinical outreach. Build effective relationships with external physicians, investigators, customers, and strategic partners. Identify and implement improvements to tissue workflows, digital pathology processes, turnaround time, consistency, scalability, business continuity, and clinical quality.
Minimum Qualifications
MD or DO degree from an accredited institution Board certification in Anatomic Pathology by the American Board of